Clinical Trial Update: Matched Unrelated Donor Stem Cell Transplantation (MUD-SCT) After Dose-reduced Conditioning for Patients With Multiple Myeloma and Relapse After Autologous SCT [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating matched unrelated donor stem cell transplantation after dose-reduced conditioning in patients with multiple myeloma who relaps…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: Universitätsklinikum Hamburg-Eppendorf | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED